New dental implants tested for Long-Term smile restoration
NCT ID NCT07544706
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 51 adults who received Neoss dental implants to replace missing front teeth. Researchers will track implant survival, bone levels, and gum health over 5 years. The goal is to see how well these implants work in the long run for this specific area of the mouth.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Neoss dental implant system (ProActive Straight and Tapered)
- What this could lead to
- If successful, this could confirm that these implants are a reliable long-term option for replacing missing front teeth.
- What could go wrong
- This is a small, single-center study with no control group, so results may not apply to everyone. Implants can fail or cause infection over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
51 people
The number who actually took part.
- Started
-
Mar 2021
- Expected to finish
-
Jul 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Signed informed consent to participate in the study. Adults ≥18 years of age requiring an implant-supported crown or bridge in the anterior maxilla (region 13-23). No prior bone augmentation required at the implant site. The implant site must be free from signs of infection. Exclusion Criteria: Individuals under 18 years of age. Individuals unable to provide informed consent due to disease, mental disorder, impaired health status, or similar conditions. Presence of systemic or local disease/condition contraindicating implant treatment. Lack of availability for follow-up visits over the 5-year study period. Previous radiotherapy to the head, neck, or jaw region. Untreated or uncontrolled periodontitis and/or peri-implantitis. Use of immunosuppressive medication. Uncontrolled diabetes mellitus. Severe alcohol and/or substance abuse.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Partial edentulism of the maxilla are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brånemark Clinic, Public Dental Health Care Service, Region of Västra Götaland, Gothenburg, Sweden
Gothenburg, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.